This is a reprint of a recent PRlog press release. CPAP can no longer be considered the "Gold Standard" of treatment for mild to moderate sleep apnea. There is a rapidly changing dynamic in the field of sleep medicine. It should be noted that CPAP and Oral Appliances are equal with "careful titration". It remains to be seen if home sleep studies can meet the "careful titration" standard.
ResMed Inc. is the world’s second- biggest maker of CPAP machines that help regulate breathing for people with sleeping disorders. They announced a 30% increase in mask sales and an increased net income of 190.1 million up from 146.4 million one year earlier. ResMed also announced a two-for-one split of the company’s outstanding shares of common stock.